Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04650672 · ClinicalTrials.gov registry record
Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.
A clinical trial, sponsored by Notal Vision.
- Completed
- Registry status
- 15
- Enrollment target
NCT04650672 is a clinical trial that has completed, run by Notal Vision. The registered enrollment target is 15 participants.
The verdict
NCT04650672 has completed, sponsored by Notal Vision.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the ability of subjects with NV-AMD to perform sequential daily self-imaging of their eyes with the self-operated Notal Home OCT device in their homes for 90 days without on-site supervision. The study will include up to 15 subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-12-08 |
| Est. Completion | 2021-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04650672
The ClinicalTrials.gov registry entry for NCT04650672 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Notal Vision, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04650672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04650672 about?
NCT04650672 is a clinical study titled "Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.". The purpose of this study is to evaluate the ability of subjects with NV-AMD to perform sequential daily self-imaging of their eyes with the self-operated Notal Home OCT device in their homes for 90 days without on-site supervision. The study will include up to 15 subjects.
What is the current status of trial NCT04650672?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2020-12-08. Estimated completion is 2021-09-30.
Who is sponsoring clinical trial NCT04650672?
This trial is sponsored by Notal Vision, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.